Name: DNLI Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: DNLI, insider trading, SEC Form 4, insider transactions

Question 1

How many SEC Form 4 insider filings does DNLI have?

Accepted Answer

Denali Therapeutics Inc. (DNLI) has 16 SEC Form 4 filings (17 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Aug 14, 2026.

Question 2

When was the most recent SEC Form 4 filing for DNLI?

Accepted Answer

The most recent Form 4 filing for DNLI on Tracefour is dated Aug 14, 2026.

Question 3

What is the net insider flow at DNLI over the last 6 months?

Accepted Answer

Over the trailing 180 days, insiders at DNLI have net sold $72K based on SEC Form 4 disclosures.

Question 4

What is the total insider buy and sell value at DNLI in the current window?

Accepted Answer

Inside the rolling window, insiders at DNLI bought $0 and sold $936K based on SEC Form 4 filings.

Question 5

Can I get alerts for DNLI insider trading?

Accepted Answer

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Denali Therapeutics Inc. (DNLI). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

						Source
Schuth Alexander O.First in 7 months	COFO and Secretary	Sale	2,857	$72K	Aug 13	SEC ↗
Schuth Alexander O.First filing	COFO and Secretary	Sale	17,218	$284K	Jan 8	SEC ↗
Watts Ryan J.First filing	President and CEO	Sale	35,198	$581K	Jan 8	SEC ↗

DNLI

Related companies